Skip to main content
Livermore
Livermore
ZHEN

Capital Analysts, LLC

SEC CIK
0001624758
Latest filing
Aug 5, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Capital Analysts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
119
Value
$59.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Capital Analysts, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026119$59.0K<0.1%00.0%UnchangedHolders
Q1 2026119$53.0K<0.1%+3+2.6%AddedHolders
Q4 2025116$52.0K<0.1%00.0%UnchangedHolders
Q3 2025116$45.0K<0.1%+29+33.3%AddedHolders
Q2 202587$39.0K<0.1%00.0%UnchangedHolders
Q1 202587$42.0K<0.1%+10+13.0%AddedHolders
Q4 202477$31.0K<0.1%−3−3.8%ReducedHolders
Q3 202480$37.0K<0.1%00.0%UnchangedHolders
Q2 202480$37.0K<0.1%+3+3.9%AddedHolders
Q1 202477$32.0K<0.1%00.0%UnchangedHolders
Q4 202377$31.0K<0.1%00.0%UnchangedHolders
Q3 202377$27.0K<0.1%00.0%UnchangedHolders
Q2 202377$27.0K<0.1%00.0%UnchangedHolders
Q1 202377$24.0K<0.1%00.0%UnchangedHolders
Q4 202277$22.0K<0.1%−19−19.8%ReducedHolders
Q3 202296$28.0K<0.1%+19+24.7%AddedHolders
Q2 202277$22.0K<0.1%00.0%UnchangedHolders
Q1 202277$20.0K<0.1%00.0%UnchangedHolders
Q4 202177$17.0K<0.1%00.0%UnchangedHolders
Q3 202177$14.0K<0.1%00.0%UnchangedHolders
Q2 202177$16.0K<0.1%00.0%UnchangedHolders
Q1 202177$17.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.